Business
BioNTech surges on COVID-19 vaccine sales forecast – The Australian Financial Review
BioNTech and partner Pfizer signed contracts to deliver some 2.2 billion doses of the two-shot vaccine this year and more than…
The technology is also being tested in cancer, in an aim to spur the immune system to fight off tumours. BioNTech has started six new patient trials this year — for a total of 15 experimental drugs in 18 trials — and said it plans to move two more potential…
Continue Reading
-
General22 hours agoPolice allowed neo-Nazi protest outside NSW parliament
-
General12 hours agoHow the dismissal of Gough Whitlam’s Labor government in 1975 was sealed by the Senate
-
General13 hours agoWallabies vs Italy rugby union Test live updates — blog, scores and stats from Udine
-
General12 hours agoA hot mess. The ‘irregulation’ of sneaky Sportsbet